natgillin/translations-raw huggingface dataset:
Blue antimora (Blue hake)
Sinja antimora
Iceland catshark
Morska mačka iz rodu Apristurus
Deep-water red crab
Globokomorska rdeča rakovica
Rabbit fish (Rattail)
Morska podgana
Conger eel
Ugor
Black (Deep-water) cardinal fish
Veleoki globokomorski kraljiček
Bluemouth (Blue mouth redfish)
Okun
Bluntnose six-gilled shark
Morski pes šesteroškrgar
Silver roughy (Pink)
Sredozemska sluzoglavka
Large-eyed rabbit fish (Ratfish)
Veleoka morska podgana
Silver scabbard fish (Cutlass fish)
Morski meč
Eelpout
Esmarkova ogorčica
Roughhead grenadier (Rough rattail)
Čebulastooki repak
Red (blackspot) seabream
Okati ribon
Round skate
Okrogla raža
Norwegian skate
Norveška kljunata raža
Straightnose rabbitfish
Kopjenosa morska podgana
Small redfish (Norway haddock)
Rdeči okun
Spiny (Deep-sea) Scorpionfish
Hrapavi okun
The power to adopt delegated acts referred to in Article 46 shall be conferred on the Commission for a period of 3 years from 1 January 2011.
Pooblastila za sprejemanje delegiranih aktov iz člena 46 se prenesejo na Komisijo za obdobje treh let od 1. januarja 2011.
The Commission shall make a report in respect of the delegated powers at the latest 6 months before the end of the three-year period.
Komisija pripravi poročilo o prenesenih pooblastilih najpozneje šest mesecev pred iztekom triletnega obdobja.
BSF
BSF*
Trachyscorpia cristulata
Trachyscorpia cristulata Atlantic thornyhead
Regulation (EU) No 1237/2010 of the European Parliament and of the Council
Uredba (EU) št. 1237/2010 Evropskega parlamenta in Sveta
amending Council Regulation (EC) No 2187/2005 as regards the prohibition of highgrading and restrictions on fishing for flounder and turbot in the Baltic Sea, the Belts and the Sound
o spremembi Uredbe Sveta (ES) št. 2187/2005 glede prepovedi višanja vrednosti ulova in omejitev za ribolov iverke in romba v Baltskem morju, Beltih in Soundu
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 43(2) thereof,
ob upoštevanju Pogodbe o delovanju Evropske unije in zlasti člena 43(2) Pogodbe,
Council Regulation (EC) No 2187/2005 [3] lays down specific technical measures for the conservation of fishery resources in the Baltic Sea, the Belts and the Sound, and in particular restrictions on fishing as regards certain species, mesh sizes and areas.
Uredba Sveta (ES) št. 2187/2005 [3] določa posebne tehnične ukrepe za ohranjanje ribolovnih virov v Baltskem morju, Beltih in Soundu in zlasti omejitve za ribolov nekaterih vrst, velikosti mrežnih očes in na nekaterih območjih.
Council Regulation (EC) No 1226/2009 of 20 November 2009 fixing the fishing opportunities and associated conditions for certain fish stocks and groups of fish stocks applicable in the Baltic Sea for 2010 [4] provides for the prohibition of highgrading and for restrictions on fishing for flounder and turbot.
Uredba Sveta (ES) št. 1226/2009 z dne 20. novembra 2009 o določitvi ribolovnih možnosti in s tem povezanih pogojev za nekatere staleže rib in skupine staležev rib, ki se za leto 2010 uporabljajo v Baltskem morju [4], določa prepoved višanja vrednosti ulova in omejitve za ribolov iverke in romba.
This prohibition and these restrictions are technical measures of a permanent nature which should no longer be included in the regulatory framework establishing annual fishing opportunities.
Ta prepoved in te omejitve so tehnični ukrepi trajne narave, ki ne bi smeli več biti vključeni v regulativen okvir o določitvi letnih ribolovnih možnosti.
From January 2011, they should therefore be incorporated into Regulation (EC) No 2187/2005.
Od januarja 2011 bi torej morali biti vključeni v Uredbo (ES) št. 2187/2005.
The term ‘Community’ used in the enacting terms of Regulation (EC) No 2187/2005 should be changed following the entry into force of the Treaty of Lisbon on 1 December 2009.
Izraz „Skupnost“, ki je uporabljen v normativnem delu Uredbe (ES) št. 2187/2005 bi bilo treba zaradi začetka veljavnosti Lizbonske pogodbe 1. decembra 2009 spremeniti.
Regulation (EC) No 2187/2005 should therefore be amended accordingly.
Uredbo (ES) št. 2187/2005 bi bilo zato treba ustrezno spremeniti.
In order to ensure the continuous application of the measures provided for in this Regulation, it should enter into force on the day following its publication in the Official Journal of the European Union,
Da bi se zagotovila neprekinjena uporaba ukrepov iz te uredbe, bi morala ta uredba začeti veljati dan po objavi v Uradnem listu Evropske unije –
Regulation (EC) No 2187/2005 is hereby amended as follows:
Uredba (ES) št. 2187/2005 se spremeni:
the following article is inserted:
vstavi se naslednji člen:
Any species which is subject to a quota and which is caught during fishing operations shall be brought aboard the vessel and subsequently landed unless this would be contrary to obligations laid down in Union fisheries regulations establishing technical, control and conservation measures in particular in this Regulation, in Regulation (EC) No 2371/2002 or in Council Regulation (EC) No 1224/2009 of 20 November 2009 establishing a Community control system for ensuring compliance with the rules of the common fisheries policy.2. the following article is inserted:
Vse vrste, ki so predmet kvot in ki so ulovljene med ribolovnimi dejavnostmi, se prinesejo na krov in nato iztovorijo, razen če bi bilo to v nasprotju z obveznostmi iz predpisov o ribištvu Unije, ki določajo tehnične, nadzorne in ohranitvene ukrepe, zlasti s to uredbo, Uredbo (ES) št. 2371/2002 ali Uredbo Sveta (ES) št. 1224/2009 z dne 20. novembra 2009 o vzpostavitvi nadzornega sistema Skupnosti za zagotavljanje skladnosti s pravili skupne ribiške politike2. vstavi se naslednji člen:
The retention on board of the following species of fish shall be prohibited where they are caught within the geographical areas and during the periods mentioned below:
Prepovedano je na krovu zadržati naslednje vrste rib, kadar so ujete znotraj zemljepisnih območij in v obdobjih, ki so navedena spodaj:
Subdivisions 26, 27, 28 and 29 south of 59° 30′ N
Podrazdelki 26, 27, 28 in 29 južno od 59°30′ SZŠ
15 February to 15 May
februar do 15. maj
15 February to 31 May
februar do 31. maj
Subdivisions 25, 26 and 28 south of 56° 50′ N
Podrazdelki 25, 26 in 28 južno od 56°50′ SZŠ
1 June to 31 July
junij do 31. julij
By way of derogation from paragraph 1, when fishing with trawls, Danish seines or similar gears with a mesh size equal to or greater than 105 mm or with gillnets, entangling nets or trammel nets with a mesh size equal to or greater than 100 mm, by-catches of flounder and turbot may be retained on board and landed within a limit of 10 % by live weight of the total catch retained on board and landed during the periods of prohibition referred to in paragraph 1.’;
Z odstopanjem od odstavka 1 se v primeru ribolova z vlečnimi mrežami, danskimi potegalkami ali podobnimi orodji z velikostjo mrežnega očesa 105 mm ali več ali z zabodnimi mrežami, zapletnimi mrežami ali trislojnimi mrežami z velikostjo mrežnega očesa 100 mm ali več prilov iverke in romba lahko zadrži na krovu in iztovori v mejah 10 % žive teže celotnega ulova, ki se zadrži na krovu in iztovori med obdobji prepovedi iz odstavka 1.“;
in Article 26(1) and (2), the noun ‘Community’, or the corresponding adjective, is replaced by the noun ‘Union’, or the corresponding adjective, and any grammatical adjustments needed as a consequence of this replacement shall be made.
v členu 26(1) in (2) se beseda „Skupnost“ ali pripadajoči pridevnik nadomesti z besedo „Unija“ ali pripadajočim pridevnikom in izvedejo vse slovnične prilagoditve, potrebne zaradi te nadomestitve.
Position of the European Parliament of 23 November 2010 (not yet published in the Official Journal) and decision of the Council of 6 December 2010.
Stališče Evropskega parlamenta z dne 23. novembra 2010 (še ni objavljeno v Uradnem listu) in odločitev Sveta z dne 6. decembra 2010.
OJ L 343, 22.12.2009, p. 1.’;
UL L 343, 22.12.2009, str. 1.“;
Regulation (EU) No 1238/2010 of the European Parliament and of the Council
Uredba (EU) št. 1238/2010 Evropskega parlamenta in Sveta
amending Annex I to Council Regulation (EEC) No 2658/87 as regards the provision of duty-free treatment for specified pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals
o spremembi Priloge I k Uredbi Sveta (EGS) št. 2658/87 v zvezi z dajatve prosto obravnavo določenih farmacevtskih aktivnih snovi, ki imajo pri Svetovni zdravstveni organizaciji „mednarodno nelastniško ime“ (INN), in določenih izdelkov, ki se uporabljajo pri proizvodnji končnih farmacevtskih izdelkov
Having regard to the Treaty on the Functioning of the European Union, and in particular Article 207 thereof,
ob upoštevanju Pogodbe o delovanju Evropske unije in zlasti člena 207 Pogodbe,
In the course of the Uruguay Round negotiations, the Community and a number of countries agreed that duty-free treatment should be granted to pharmaceutical products falling within the Harmonised System (HS) Chapter 30 and HS headings 2936, 2937, 2939 and 2941 as well as to designated pharmaceutical active ingredients bearing an ‘international non-proprietary name’ (INN) from the World Health Organization, specified salts, esters and hydrates of such INNs, and designated pharmaceutical intermediates used for the production and manufacture of finished pharmaceuticals.
V okviru urugvajskega kroga pogajanj so se Skupnost in številne države dogovorile, da bi morala biti dajatve prosta obravnava dodeljena farmacevtskim izdelkom, uvrščenim v poglavje 30 harmoniziranega sistema (HS) in pod tarifne številke HS 2936, 2937, 2939 in 2941, ter na določene farmacevtske aktivne snovi, ki imajo pri Svetovni zdravstveni organizaciji „mednarodno nelastniško ime“ (INN), določene soli, estre in hidrate takšnih INN in določene vmesne izdelke farmacevtske proizvodnje, ki se uporabljajo za proizvodnjo in izdelavo končnih farmacevtskih izdelkov.
The results of the discussions, as set out in the Record of Discussions, were incorporated into the tariff schedules of the participants annexed to the Marrakesh Protocol to the General Agreement on Tariffs and Trade (GATT) 1994.
Izidi razprav, določeni v Poročilu o razpravah, so bili vključeni v tarifne sezname udeležencev, priložene Marakeškemu protokolu k Splošnemu sporazumu o carinah in trgovini (GATT) 1994.
Participants concluded that representatives of World Trade Organization (WTO) members, party to the Record of Discussions, would meet under the auspices of the Council for Trade in Goods of the WTO, normally at least once every three years, to review the product coverage with a view to including, by consensus, additional pharmaceutical products for tariff elimination.
Udeleženci so sklenili, da naj bi se predstavniki članic Svetovne trgovinske organizacije (STO), ki so sodelovale pri Poročilu o razpravah, vsaj enkrat na tri leta srečali pod pokroviteljstvom Sveta STO za trgovino z blagom, da pregledajo seznam izdelkov in po potrebi soglasno vključijo dodatne farmacevtske izdelke, za katere velja odprava tarif.
Three such reviews have taken place with the result that a certain number of additional INNs and pharmaceutical intermediates used for the production and manufacture of finished pharmaceuticals have been granted duty-free treatment, that some of those intermediates have been transferred to the list of INNs, and that the list of specified prefixes and suffixes for salts, esters or hydrates of INNs has been expanded.
Po treh takšnih pregledih je bila dajatve prosta obravnava dodeljena določenemu številu dodatnih INN in vmesnih farmacevtskih izdelkov, ki se uporabljajo za proizvodnjo in izdelavo končnih farmacevtskih izdelkov, nekateri od navedenih vmesnih izdelkov so bili prenešeni na seznam INN in seznam določenih predpon in pripon za soli, estre ali hidrate INN je bil razširjen.
Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff [2] established the Combined Nomenclature (CN) and set out the conventional duty rates of the Common Customs Tariff.
Uredba Sveta (EGS) št. 2658/87 z dne 23. julija 1987 o tarifni in statistični nomenklaturi ter skupni carinski tarifi [2] je uvedla kombinirano nomenklaturo (KN) in določila konvencionalne stopnje dajatve skupne carinske tarife.
In order to ensure that the measures provided for in this Regulation apply from 1 January 2011, it should enter into force on the day following that of its publication,
Za zagotovitev, da se ukrepi iz te uredbe začnejo uporabljati s 1. januarjem 2011, bi morala ta uredba začeti veljati dan po objavi –
Annexes 3, 4 and 6 of Section II of Part Three of Annex I to Regulation (EEC) No 2658/87 (Lists of pharmaceutical substances which qualify for duty-free treatment) are hereby amended as follows:
Priloge 3, 4 in 6 oddelka II tretjega dela Priloge I k Uredbi (EGS) št. 2658/87 (seznam farmacevtskih snovi, upravičenih do dajatev proste obravnave) se spremenijo:
As from 1 January 2011 the Union shall extend duty-free treatment to the INNs listed in Annex I.
Unija s 1. januarjem 2011 razširi dajatve prosto obravnavo na INN iz Priloge I.
As from 1 January 2011 the list of prefixes and suffixes which, in combination with the INNs included in the pharmaceutical sectoral arrangement and its revisions, describe the salts, esters or hydrates of INNs which are also eligible for duty-free treatment, on condition that they are classifiable in the same six-digit HS subheading as the corresponding INN, shall be amended as set out in Annex II.
Seznam predpon in pripon, ki skupaj z INN, ki so vključeni v farmacevtsko sektorsko ureditev in njene preglede, poimenujejo soli, estre ali hidrate INN, ki so pod pogojem, da jih je mogoče uvrstiti pod isto šest-mestno podštevilko HS kot pripadajoče INN, prav tako upravičeni do dajatve proste obravnave, se s 1. januarjem 2011 spremeni, kakor je določeno v Prilogi II.
As from 1 January 2011 the Union shall extend duty-free treatment to the pharmaceutical intermediates used in the production and manufacture of finished pharmaceuticals, listed in Annex III.
Unija s 1. januarjem 2011 razširi dajatve prosto obravnavo na farmacevtske vmesne izdelke, navedene v Prilogi III, ki se uporabljajo za proizvodnjo in izdelavo končnih farmacevtskih izdelkov.
As from 1 January 2011 the pharmaceutical intermediates listed in Annex IV shall be withdrawn from the list of such compounds receiving duty-free treatment.
S 1. januarjem 2011 se vmesni farmacevtski izdelki, navedeni v Prilogi IV, umaknejo s seznama takšnih sestavin, ki jim je odobrena dajatve prosta obravnava.
List of international non-proprietary names (INNs) to be added to the list of products receiving duty-free treatment included in Annex 3 to Annex I to Regulation (EEC) No 2658/87
Seznam mednarodnih nelastniških imen (INN), ki jih je treba dodati na seznam izdelkov za dajatev prosto obravnavo, vključenih v Prilogo 3 Priloge I k Uredbi (EGS) št. 2658/87
iodofiltic acid (123
jodofilitska kislina (123
eprodisate
eprodizat
naproxcinod
naprokscinod
tramiprosate
tramiprozat
cinaciguat
cinacigvat
choline fenofibrate
holin fenofibrat
gabapentin enacarbil
gabapentin enakarbilat
olesoxime
olezoksim
levonebivolol
levonbivolol
imisopasem manganese
imizopazem-mangan
cediranib
kediranib
macitentan
makitentan
riociguat
riokigvat
isavuconazonium chloride
izavukonazonijev klorid
aclidinium bromide
aklidinijev bromid
cenersen
kenersen
idrabiotaparinux sodium
natrijev idrabiotaparinuksat
quarfloxin
kvarfloksin
simotaxel
simotaksel
lodenafil carbonate
lodenafilijev karbonat
levomefolic acid
levomefolna kislina
dexamethasone cipecilate
deksametazoncipecilat
fluticasone furoate
flutikazonfuroat
methylnaltrexone bromide
metilnaltreksonijev bromid
darotropium bromide
darotropijev bromid
ferric carboxymaltose
železova karboksimaltoza
semuloparin sodium
natrijev semuloparinat
(light chain)
(lahka veriga)
(heavy chain)
(težka veriga)
tucotuzumab celmoleukin
tukotuzumab celmolevkin
atacicept
atakicept
vatreptacog alfa (activated)
vatreptakog alfa (aktiviran)
catridecacog
catridekakog
alacizumab pegol
alakizumab pegol
bucelipase alfa
bucelipaza alfa
pegloticase
pegloticaza
velaglucerase alfa
velagluceraza alfa
azoximer bromide
azoksimerijev bromid
List of prefixes and suffixes which, in combination with the INNs of Annex 3 to Annex I to Regulation (EEC) No 2658/87, describe the salts, esters or hydrates of INNs; these salts, esters and hydrates are free of duty, on condition that they are classifiable in the same six-digit HS subheading as the corresponding INN
Seznam predpon in pripon, ki v kombinaciji z imeni INN iz Priloge 3 Priloge I k Uredbi (EGS) št. 2658/87 poimenujejo soli, estre ali hidrate INN; te soli, estri in hidrati so prosti dajatev pod pogojem, da jih je mogoče uvrstiti pod isto šest-mestno podštevilko HS kot pripadajoče INN
The references to ‘International Nonproprietary Names (INN) for pharmaceutical substances, names for radicals and groups, comprehensive list 2004’ are replaced by ‘International Nonproprietary Names (INN) for pharmaceutical substances, names for radicals, groups and others, comprehensive list 2007’.
Sklici na „mednarodna nelastniška imena (INN) za farmacevtske snovi, imena za radikale in skupine, izčrpen seznam iz leta 2004“ se nadomestijo z „mednarodnimi nelastniškimi imeni (INN) za farmacevtske snovi, imeni za radikale in skupine, izčrpnim seznamom iz leta 2007“.
The following prefixes or suffixes are added to the list included in Annex 4 to Annex I to Regulation (EEC) No 2658/87:
Seznamu, vključenem v Prilogi 4 Priloge I k Uredbi (EGS) št. 2658/87, se dodajo naslednje predpone ali pripone:
(4-iminobutane-1,4-diyl)sulfanediyl[(3RS)-2,5-dioxopyrrolidine-1,3-diyl]-1,3-phenylenecarbonyl and forming an N-benzoyl derivative of a primary amine group of diphtheria [550-L-phenylalanine]toxin from Corynebacterium diphtheriae-(26-560)-peptide (INNCN)
(4-iminobutan-1,4-diil)sulfandiil[(3RS)-2,5-dioksopirolidin-1,3-diil]-1,3-fenilenkarbonil in sestavlja derivat N-benzoila primarne aminoskupine difterije [550-L-fenilalanin]toksin iz Corynebacterium diphtheriae-(26-560)-peptida (INNCN)
L-lysyl-L-alanyl-L-serylglycylglycine (linker) fusion protein with des-(365-380)-[Asn364,Val407,Ser515,Gln590,Gln606,Arg613]exotoxin A (Pseudomonas aeruginosa)-(251-613)-peptide (toxin with region IA and first 16 residues of region IB deleted) (INNCN)
L-lizil-L-alanil-L-serilglicilglicin (linker) fuzijski protein z des-(365-380)-[Asn364,Val407,Ser515,Gln590,Gln606,Arg613]eksotoksinom A (Pseudomonas aeruginosa)-(251-613)-peptidom (toksin z izbrisano regijo IA in izbrisanimi prvimi 16 ostanki regije IB) (INNCN)
ceribate (INNRG)
keribat (INNRG)
rac-2,3-dihydroxypropyl carbonate (ester) (INNCN)
rak-2,3-dihidroksipropil karbonat (ester) (INNCN)
cyclohexanecarboxylate (ester), cyclopropanecarboxylate (ester) (INNCN)
kikloheksankarboksilat (ester), kiklopropankarboksilat (ester) (INNCN)
des-B30-alanine (INNCN)
des-B30-alanin (INNCN)
glycylglycyl-L-proline (linker) fusion protein with enterotoxin type A (Staphylococcus aureus)-(1-33)-peptidyl-L-seryl[Ser36,Ser37,Glu38,Lys39,Ala41,Thr46,Thr71,Ala72,Ser75,Glu76,Glu78,Ser80,Ser81,Thr214,Ser217,Thr219,Ser220,Ser222,Ser224]enterotoxin type E (Staphylococcus aureus)-(32-230)-peptide (synthetic superantigen SEA/E-120) (INNCN)
glicilglicil-L-prolin (linker) fuzijski protein z enterotoksinom tipa A (Staphylococcus aureus)-(1-33)-peptidil-L-seril[Ser36,Ser37,Glu38,Lys39,Ala41,Thr46,Thr71,Ala72,Ser75,Glu76,Glu78,Ser80,Ser81,Thr214,Ser217,Thr219,Ser220,Ser222,Ser224]enterotoksin tipa E (Staphylococcus aureus)-(32-230)-peptid (sintetičen superantigen SEA/E-120) (INNCN)
β-D-glucopyranosiduronic acid [oside] (INNCN)
β-D-glukopiranosiduronska kislina [ozid] (INNCN)
protein PAP (Phytolacca americana antiviral) (INNCN)
protein PAP (Phytolacca americana protivirus) (INNCN)
The systematic name of the following prefix or suffix is amended as follows:
Sistematično ime naslednje predpone ali pripone se spremeni:
ricin A chain (INNCN)
ricin A veriga (INNCN)
List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be added to the list of products receiving duty-free treatment included in Annex 6 to Annex I to Regulation (EEC) No 2658/87
Seznam farmacevtskih vmesnih izdelkov, tj. sestavin, ki se uporabljajo za proizvodnjo končnih farmacevtskih izdelkov, ki jih je treba dodati na seznam dajatev prostih izdelkov, vključenih v Prilogo 6 Priloge I k Uredbi (EGS) št. 2658/87
[4-amino-N-(pyrimidin-2(1H)-ylidene-κN1)benzenesulfonamidato-κO]silver
[4-amino-N-(pirimidin-2(1H)-iliden-κN1)benzensulfonamidato-κO]srebro
4-chlorobutyl 2-nitrobenzenesulfonate
4-klorobutil 2-nitrobenzensulfonat
2-(2-[(6-bromohexyl)oxy]ethoxymethyl)-1,3-dichlorobenzene
2-(2-[(6-bromoheksil)oksi]etoksimetil)-1,3-diklorobenzen
4-(5-bromo-2-chlorobenzyl)phenyl ethyl ether
4-(5-bromo-2-klorobenzil)fenil-etil-eter
iodomethyl pivalate
jodometil pivalat
(3R)-3-methylhexanoic acid
(3R)-3-metilheksanojska kislina
1-(2-ethylbutyl)cyclohexanecarboxylic acid
1-(2-etilbutil)cikloheksankarboksilna kislina
trans-4-(propan-2-yl)cyclohexanecarboxylic acid
trans-4-(propan-2-il)cikloheksankarboksilna kislina
5′-chloro-2′-hydroxy-3′-nitrobiphenyl-3-carboxylic acid
5′-kloro-2′-hidroksi-3′-nitrobifenil-3-karboksilna kislina
(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)(oxo)acetic acid
(3-hidroksitriciklo[3.3.1.1(3,7)]dec-1-il)(okso)ocetna kislina
2,5-bis(2,2,2-trifluoroethoxy)benzoic acid
2,5-bis(2,2,2-trifluoroetoksi)benzojska kilsina
(3α,5β)-3-hydroxy-7-oxocholan-24-oic acid
(3α,5β)-3-hidroksi-7-oksoholan-24-ojska kislina
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate
(1R,2S)-2-(3,4-difluorofenil)ciklopropanaminij (2R)-hidroksi(fenil)etanoat
2-(2,3-dihydro-1H-inden-2-yl)propan-2-amine hydrochloride
2-(2,3-dihidro-1H-inden-2-il)propan-2-amonijev klorid
2-(4-chloro-3-ethylphenyl)ethanamine hydrochloride
2-(4-kloro-3-etilfenil)etanamonijev klorid
N-(4-tert-butylbenzyl)-2-(4-chloro-3-ethylphenyl)ethanamine
N-(4-tert-butilbenzil)-2-(4-kloro-3-etilfenil)etanamin
(2R)-1-(5-bromo-2,3-difluorophenoxy)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]aminopropan-2-ol hydrochloride
(2R)-1-(5-bromo-2,3-difluorofenoksi)-3-[1-(2,3-dihidro-1H-inden-2-il)-2-metilpropan-2-il]aminopropan-2-olijev klorid
[2-(chloromethyl)-4-(dibenzylamino)phenyl]methanol hydrochloride
[2-(klorometil)-4-(dibenzilamino)fenil]metanol klorid
antimonic acid – 1-deoxy-1-(methylamino)-D-glucitol (1:1)
antimonska kislina – 1-deoksi-1-(metilamino)-D-glucitol (1:1)
ethyl (2E)-3-(3-[(2R)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino-2-hydroxypropyl]oxy-4,5-difluorophenyl)prop-2-enoate hydrochloride
etil (2E)-3-(3-[(2R)-3-[1-(2,3-dihidro-1H-inden-2-il)-2-metilpropan-2-il]amino-2-hidroksipropil]oksi-4,5-difluorofenil)prop-2-enoat v obliki klorida
ethyl 3-(3-[(2R)-3-[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino-2-hydroxypropyl]oxy-4,5-difluorophenyl)propanoate hydrochloride
etil 3-(3-[(2R)-3-[1-(2,3-dihidro-1H-inden-2-il)-2-metilpropan-2-il]amino-2-hidroksipropil]oksi-4,5-difluorofenil)propanoat v obliki klorida
(2E)-4-(dimethylamino)but-2-enoic acid hydrochloride
(2E)-4-(dimetilamino)but-2-enojska kislina v obliki klorida
(3S,5R)-3-amino-5-methyloctanoic acid
(3S,5R)-3-amino-5-metiloktanojska kislina
(3S,5R)-3-amino-5-methyloctanoic acid hydrochloride
(3S,5R)-3-amino-5-metiloktanojska kislina v obliki klorida
4-(1-aminocyclopropyl)-2,3,5-trifluorobenzoic acid
4-(1-aminociklopropil)-2,3,5-trifluorobenzojska kislina
4-fluoro-L-leucine – ethyl hydrogen sulfate (1:1)
4-fluoro-L-levcin – etil hidrogen sulfat (1:1)
triphenylacetic acid – 4-(1R)-2-[(6-2-[(2,6-dichlorobenzyl)oxy]ethoxyhexyl)amino]-1-hydroxyethyl-2-(hydroxymethyl)phenol (1:1)
trifenilocetna kislina – 4-(1R)-2-[(6-2-[(2,6-diklorobenzil)oksi]etoksiheksil)amino]-1-hidroksietil-2-(hidroksimetil)fenol (1:1)
2-[(tert-butoxycarbonyl)amino]-3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-ylacetic acid
2-[(tert-butoksikarbonil)amino]-3-hidroksitriciklo[3.3.1.1(3,7)]dec-1-ilocetna kislina
2,3-diaminobenzamide dihydrochloride
2,3-diaminobenzamidijev diklorid